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Long-chain PUFA (LCPUFA) supplementation of formula can have beneficial effects on neurodevelopmental outcome in early infancy, but
uncertainty exists regarding effects after 6 months. The present study is the first to investigate whether consumption by term infants of formula
containing LCPUFA for the first 2 months after birth improves neurological condition of these children at 9 years of age. A prospective, double-
blind, randomised control study was performed in two groups of healthy term infants: a control group with standard formula (n 169) and a
LCPUFA-supplemented group (LF; n 146). A breast-fed group (BF; n 159) served as a reference. At age 9 years, children were neurologically
assessed according to Touwen, resulting in a Neurological Optimality Score and information on severity and type of minor neurological dysfunc-
tion (MND). Information on potential confounders was collected at enrolment and follow-up. Multivariate analyses were carried out to evaluate the
effect of nutrition while adjusting for confounders. Attrition (28 %) was selective: drop-outs in the LF group were more often boys and had a
significantly lower mental developmental index at 18 months. Neurological optimality and severity and type of MND at 9 years did not differ
between the two formula groups. Children in the BF group showed significantly less often fine manipulative dysfunction than formula-fed children.
In conclusion, LCPUFA supplementation of formula during the first 2 postnatal months in healthy term infants does not alter neurological function
at school age. The study confirmed that breast-fed infants have a slightly better neurodevelopmental outcome than formula-fed infants.
Long-chain PUFA: Neurodevelopment: Children: Breast-feeding: Groningen LCPUFA study
Long-chain PUFA (LCPUFA) have become a major focus of
attention in the field of infant nutrition and development.
The Cochrane reviews of the group of Simmer(1,2) indicated
that supplementation of formula with LCPUFA, in particular
DHA (22 : 6n-3) and arachidonic acid (20 : 4n-6), in general
does not affect motor, visual and cognitive outcome. However,
when the age at which the child is assessed is taken into
account the results are less straightforward. Outcome of
LCPUFA-supplemented formula groups (especially DHA
supplementation) is better in early infancy, but studies
which assessed outcome between 6 and 24 months usually
did not demonstrate differences between supplemented and
non-supplemented groups(1). The latter age period is, however,
known for its insensitivity to reveal adverse effects of
exposures during early ontogeny(3). Thus, the absence of an
effect between 6 and 24 months does not preclude an effect
at a later age. Currently data on the effect of LCPUFA
supplementation of formula on neurodevelopmental outcome
at school age are lacking.
The present study aims at investigating whether consump-
tion by term infants of formula containing LCPUFA for the
first 2 months after birth improves the neurological condition
of these children at 9 years of age. Neurological development
is one of the domains in which the early beneficial effects
of LCPUFA manifest themselves. The study is an extension
of the original Groningen LCPUFA study, a randomised
controlled trial on the effect of supplementation of formula
with LCPUFA during the first 2 postnatal months. At the
age of 9 years a standardised and age-specific neurological
examination was carried out, which specifically assesses
minor neurological dysfunction (MND). MND is considered
a valid measure of neurological condition that shows a
strong relationship with pre- and perinatal adversities(3).
Earlier, Lanting et al.(4) reported that breast-feeding was
associated with less MND at school age than formula-feeding.
The primary outcome measure of the present study was the
Neurological Optimality Score (NOS). The NOS uses the
optimality concept to summarise neurological condition; it
provides a sensitive measure of the child’s overall neurologi-
cal status. Secondary outcome measures were clinical
neurological condition in terms of severity and type of
MND. Two major forms of MND can be distinguished:
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simple and complex MND. Simple MND can be regarded as
a typical but non-optimal form of brain function, whereas
complex MND is the clinically relevant form of MND.
Based on the literature, we hypothesise that the LCPUFA-
supplemented children perform better than the children who
received standard formula and that breast-fed children perform
better than the formula-fed children. A better performance will
be reflected in a higher NOS, less and less severe MND, and a
lower prevalence of specific neurological dysfunctions. The
effect of sex on relationships between postnatal supplemen-
tation and neurological outcome was also determined, as
previous studies suggested the possibility of an advantage of
LCPUFA supplementation in males(5).
Methods
Participants
Details of the study design have been described previously(6).
Mothers of 314 infants chose to bottle-feed their child and 160
opted for breast-feeding. The infants receiving formula were
randomised into a standard formula group (control formula,
CF; n 169) and a LCPUFA-supplemented formula group
(LF; n 145). Standard formula consisted of Nutrilon
Premiumw (Nutricia, Zoetermeer, The Netherlands). For the
supplemented formula, the lipid fraction of Nutrilon Pre-
miumw was enriched with 0·45 % (by weight) arachidonic
acid and 0·30 % (by weight) DHA. The duration of supplemen-
tation was 2 months. In case breast-feeding stopped before
2 months, the infant received LCPUFA-supplemented formula
until the age of 2 months, and remained in the BF group. All
formula-fed infants received control formula between 2 and
6 months. The children underwent neurodevelopmental assess-
ment at 3 and 18 months of age(6,7). Follow-up was achieved in
84 % (3 months(6)) and 92 % (18 months(7)) of the original
groups. All children seen at the 18-months follow-up were eli-
gible for re-testing at 9 years. At the 9-year follow-up, both
parents and examiners were unaware of the type of formula-
feeding the infant had received. The examiners also were
blind to the type of milk fed during the first 8 weeks.
Procedures
Neurological condition of the children was evaluated with the
Touwen (1979) examination(8), which is a standardised, age-
specific assessment designed for the assessment of MND.
Essential in the diagnostics of MND is the presence of
coherent clusters of signs. Single signs do not have clinical
significance; signs only have significance when they co-
occur (cluster) with other signs within a functional domain.
The examination is organised into eight functional domains:
posture and muscle tone; reflexes; dyskinesia; coordination;
fine manipulative ability; associated movements; sensory
deficits; cranial nerve functioning. The examination results
in a clinical classification: normal; simple MND; complex
MND; or abnormal. A child is considered neurologically
abnormal in the presence of a clear neurological disorder
such as cerebral palsy. Simple MND denotes the presence of
one or two domains of dysfunction and is present in about
15–20 % of children. It has little clinical relevance and can
be regarded as typical but non-optimal brain functioning, in
other words as a minor neurological difference. Complex
MND denotes the presence of more than two domains of
dysfunction and is the clinically relevant form of MND.
In an aetiological sense it can be considered a borderline
form of cerebral palsy as it is linked to a chain of pre- and
perinatal adversities(3,9). A child is classified as neurologically
normal when no domains are scored as deviant or in case of
the isolated presence of a mild dysfunction in reflex activity.
The neurological examination according to Touwen(8) has a
good intra-rater, inter-rater and test–retest reliability; the k
statistics of the three forms of reliability for neurological
classification ranged between 0·71 and 0·83(9). Its construct
validity is reflected by the differential relationship for simple
and complex MND with prenatal and perinatal adversities:
adverse conditions during early life have a weak to moderate
relationship with simple MND and a strong correlation with
complex MND(3,10). Predictive validity is good; this is reflected
by the relationship between the severity of MND at 9 years
and the risk of MND at 12 and 14 years and that of learning
and behavioural problems at 9 and 14 years(3,11,12).
The study’s primary outcome parameter was the NOS. The
NOS uses the optimality concept to summarise neurological
condition and provides a sensitive measure of the child’s over-
all neurological status. The sensitivity of the NOS to detect
effects of early nutrition may be illustrated by the study of
Bouwstra et al.(13) which demonstrated that prenatal fatty
acid status was related to NOS at 18 months, but not to
outcome measured with the Bayley Scales of Infant Develop-
ment. For sixty-four items, representing the entire neurological
examination, an optimal range was identified (see online
Supplemental Table 1). The total number of items with a
value within the predefined optimal range formed the NOS
of a child. It should be realised that there is a conceptual
difference between normality and optimality, as the range
for optimal behaviour is narrower than that of normal beha-
viour(14). The NOS may be regarded as a quantitative and
more subtle expression of the clinical neurological condition.
This also means that the two measures are highly correlated(15)
(present study r ¼ 20·691; P,0·001). The quantitative and
precise nature of the NOS makes it a suitable instrument to
evaluate subtle deviations in neurodevelopmental outcome.
The NOS has previously been used in infancy and
pre-school-age children; in the present study NOS principles
are applied for the first time at the age of 9 years.
Data on prenatal and perinatal conditions had been collected
during enrolment with the help of the Obstetrical Optimality
Score (OOS). The OOS describes the obstetrical conditions
ranging from the parents’ socio-economic status to the infant’s
condition immediately after birth(15). At the 18-months assess-
ment, maternal verbal intelligence quotient (IQ) was estimated
using a very abbreviated version of the Wechsler Adult Intel-
ligence Scale, WAIS III, limited to the subtests information
and vocabulary(16). Social condition was documented with
the Home Observation for Measurement of the Environment
(HOME) inventory(17). The HOME contains forty-five
items clustered into six subscales: Parental Responsivity;
Acceptance of Child; Organization of the Environment;
Learning Materials; Parental Involvement; Variety in Experi-
ence. At the 9-year follow-up information was collected on
parental education and profession, the child’s medical history,
family composition and nutritional habits.

















Depending on the wish of the participants, the assessment
was carried out in the hospital or at home. The present
study was conducted according to the guidelines laid down
in the Declaration of Helsinki and all procedures involving
human subjects were approved by the Ethics Committee of
the Groningen University Hospital. Written informed consent
was obtained from all subjects. The trial is registered under
ISRCTN52788665.
Statistical analysis
Statistical analysis focused on differences in neurological
outcome between the two randomised formula groups. In
addition, differences between the breast-fed group and the
formula groups were analysed. Specific attention was paid to
the effect of site of investigation and maternal estimated
verbal IQ. Neurological classification, specific clusters of
dysfunction and NOS were not normally distributed. Univari-
ate analyses were performed with the Mann–Whitney U test
and the Kruskall–Wallis test.
In order to analyse the effect of nutritional group on
neurological classification and type of dysfunction while
taking into account the role of potential confounders, logistic
regression analyses were performed. The following confoun-
ders, associated with neurological outcome at P,0·20, were
entered into the analyses: sex; maternal smoking during
pregnancy; duration of the second stage of delivery; birth
weight; OOS; maternal hypertension during pregnancy;
Apgar score 3 min after birth; maternal educational
level. To investigate the effect of nutritional group and the
above-mentioned confounders on NOS, multiple linear
regression was applied to the NOS transformed to the fifth
power. This transformation to normality was identified by
the Box–Cox method applied to regression model residuals
(the NOS was skewed to the left).
The multivariate analyses on the effect of nutritional group
were carried out in two steps. In the first analysis the effect of
the type of formula was assessed; in the second analysis the
difference between formula- and breast-feeding was evaluated.
P#0·05 was considered statistically significant. Statistical
analyses were performed using SPSS 14.0 for Windows
(SPSS, Inc., Chicago, IL, USA).
Results
All children who were tested at 18 months were invited for
follow-up at 9 years (n 436); 341 of the 474 children of the
original study agreed to participate, ninety-one children in
the LF group (63 %), 123 children in the CF group (73 %)
and 127 children in the BF group (79 %; Fig. 1). Obstetrical
data of the study groups and sociodemographic characteristics
of the parents are described in Table 1. In general, obstetrical
and social characteristics of the children who were and who
were not assessed at 9 years were comparable. Yet, children
who were not assessed at 9 years had shown significantly
more often normal-optimal general movements at 3 months
than those who had been assessed, meaning that children
with an optimal neuromotor condition in early infancy were
under-represented in the follow-up of the three groups at
9 years (P¼0·003). In addition, attrition in the LF group
Table 1. Obstetrical and social characteristics of the three groups assessed at 9 years
BF group (n 127) LF group (n 91) CF group (n 123)
Variable n % n % n %
Retention (% of original study groups) 79 63 73
Sex
Boys 64 42 71
Girls 63 49 52
Duration of second stage of delivery (min)
Median 25 22 22
Range 2–138 1–120 1–146
Birth weight (g)
Mean 3588 3527 3518
SD 436 498 473
Apgar score 3 min after birth
Median 10 10 10
Range 5–10 7–10 7–10
Maternal education*
High (university education or vocational college) 60 49 13 15 15 13
Medium (college graduate or junior vocational college) 57 46 52 60 85 72
Low (no education or primary education) 6 5 22 25 18 15
Presence of maternal smoking during pregnancy† 25 20 31 34 44 36
Presence of maternal hypertension during pregnancy 11 9 11 12 21 17
HOME
Median 44 43 43
Range 39–45 32–45 35–45
OOS
Median 60 59 59
Range 43–69 50–67 49–67
BF, breast-fed; LF, long-chain PUFA-supplemented formula-fed; CF, control formula-fed; HOME, Home Observation for the Measurement of the Environment inventory;
OOS, Obstetrical Optimality Score.
* Significant difference between all groups (P¼0·001).
† Significant difference between BF and LF/CF combined (P¼0·003).

















was more selective than in the other groups. First, in the
LF group more boys did not take part in the follow-up
(thirty-five boys and seventeen girls) compared with the BF
group (fifteen boys and seventeen girls) and the CF group
(twenty-four boys and seventeen girls). Second, the mental
developmental index of the Bayley Scales of Infant Develop-
ment(18,19) at 18 months of the children of the LF group who
were not assessed at 9 years was significantly lower than that
of LF children who did participate in the follow-up at 9 years
(P¼0·007). A similar selective attrition was not present in the
CF and BF groups.
Neurological condition at 9 years was not affected by the
site of investigation (in the hospital or at home), by current
consumption of fish (dichotomised as at least once per week
or less than once per week) and maternal verbal IQ. The
NOS of children in the LF and CF groups did not differ; in
both groups the median NOS score was 57. The NOS of
formula-fed children (LF and CF groups) was significantly
lower than that of breast-fed children (median values 57 and
58, respectively, Mann–Whitney, P¼0·008; see also Table 2
for more specifics on the BF group). Multiple regression
(Table 3) confirmed that the NOS was not affected by
LCPUFA supplementation. The analysis revealed an inter-
action between sex and type of feeding: girls who had been
breast-fed had a higher NOS than girls who had been for-
mula-fed. Other factors associated with a higher NOS were
higher birth weight and an OOS above the 10th percentile.
The effects presented in Table 3 are on the transformed
scale of NOS. An effect of size, for example, 0·4 on the
transformed scale can be interpreted on the original scale as
follows. A NOS value of 57 transforms to (57/50)5 ¼ 1·9254;
increasing this by 0·4 gives 2·3254; transforming this back
to the original scale gives 50 £ 2·32 540·2 ¼ 59·2. Note that
as the width of most confidence intervals in Table 3 is
below 0·4, the CI width thus becomes about 2 points on the
original NOS scale. The NOS at 9 years showed a statistically
significant association with the mental developmental index
of the Bayley Scales of Infant Development at 18 months
(Spearman r ¼ 0·193; P,0·0001).
Of the children, 46 to 54 % had a normal neurological
condition, 36–39 % showed simple MND and 10–15 % of
children had complex MND. Neurological classification did
not differ between the randomised formula groups. Children
in the BF group tended to have a slightly better neurological
condition than the children in the formula-fed groups,
but the difference did not reach statistical significance
(P¼0·17; Table 4).
LF and CF groups did not differ in the prevalence of
specific types of dysfunction. Children of the BF group,
however, showed significantly less often fine manipulative
Table 2. Duration of exclusive breast-feeding and Neurological
Optimality Score
Duration of exclusive
breast-feeding. . . 3–5 weeks 6–8 weeks .8 weeks
Children (n) 25 23 62
Neurological
Optimality Score
Median 58 58 58
Range 51–63 50–63 47–64















Six lost to follow-up*
Ten lost to follow-up*
Twelve lost to follow-up*
Twenty lost to follow-up
Seven withdrew consent
Thirty-five lost to follow-up
Nine withdrew consent






Fig. 1. Flow diagram of children enrolled in the study and followed up until 9 years of age. * for more detailed information, see Bouwstra et al.(7). LCPUFA,
long-chain PUFA.

















dysfunction than formula-fed children (BF 16 %, LF 30 %,
CF31 %; BF v. formula groups; P¼0·002). This was con-
firmed in multivariate analysis (Table 5) with the following
contributing factors: OOS below the 10th percentile; male
sex; maternal smoking during pregnancy; duration of the
second stage of delivery. Breast-fed and formula-fed children
did not differ in the prevalence of other types of neurological
dysfunction.
Discussion
The present study indicated that consumption by term infants
of formula containing LCPUFA for the first 2 months after
birth did not affect neurological condition at 9 years. The
study also revealed that fine manipulative ability of breast-
fed children was better than that of formula-fed children.
A major limitation of the study is its attrition. Overall
attrition was 28 %, which – over a period of 9 years – can
be regarded as relatively favourable(20). However, a major
problem in the present study was the selective nature of attri-
tion, that is, a selective loss of boys and children with a worse
cognitive development at 18 months in the LF group. The
selective attrition interfered with the randomised design of
the study. While the multiple regression analysis can alleviate
the effect of attrition if the missingness of data depends only
on known covariates, it cannot annihilate the effect of severe
(‘missing not at random’) attrition.
Some of the breast-fed children received a few weeks of
formula supplemented with LCPUFA (Table 2). This may
be considered a limitation, as it may have influenced any
differences between the supplemented formula group and the
breast-fed group. However, the finding that the neurological
condition of the LF group did not differ from the CF group
reduces the likelihood that differences between the LF and
BF groups were affected by the mixed composition of the
BF group.
The prevalence of MND in the present study is another
point which deserves methodological attention. The preva-
lence is higher than indicated by earlier estimations of MND
in the general population(3). This may raise questions regard-
ing the representativeness of the current sample of healthy
full-term infants. However, neurological evaluation of these
groups at 3 months indicated that neurological status was
representative for the general population(6,21). Possibly, the
relatively high prevalence of MND in the present study
reflects the general trend of worsening neuromotor condition
in the last decades(22).
The strengths of the study are its randomised design and its
assessor-blinded evaluation with an internationally recognised,
sensitive technique to evaluate neurological condition(4,23 – 26).
Based on the width of the confidence intervals, it is concluded
that the LF v. CF differences do not exceed 2·2 points on the
NOS scale.
This is the first study reporting the effect of supplemen-
tation of formula with LCPUFA in healthy term infants on
neurological condition at school age. Using the NOS, a sensi-
tive indicator of neurological condition, an effect of 2 months
of postnatal LCPUFA supplementation on neurological status
at 9 years could not be demonstrated. Bearing in mind the fact
that the LF group suffered from selective attrition of children
with a lower mental developmental index at 18 months, the
present study indicates that LCPUFA supplementation
during the first 2 postnatal months does not promote neuro-
logical condition at school age.
The present finding of a subtle positive association
between breast-feeding and neurodevelopmental outcome,
Table 3. Results of linear regression analysis of factors contributing to
the normalised Neurological Optimality Score (NOS): (NOS/50)5*
Variables Effect 95 % CI P
Type of feeding by sex
Males
LF v. CF (reference) 0·173 20·055, 0·401 0·137
BF v. CF 0·141 20·057, 0·340 0·162
BF v. LF 20·031 20·261, 0·198 0·788
Females
LF v. CF 20·100 20·328, 0·128 0·389
BF v. CF 0·238 0·024, 0·452 0·029
BF v. LF 0·338 0·122, 0·555 0·002
Sex by type of feeding
CF female v. male 0·367 0·156, 0·578 0·001
BF female v. male 0·464 0·262, 0·665 0·001
LF female v. male 0·094 20·150, 0·338 0·450
Birth weight (kg) 0·147 0·012, 0·282 0·032
OOS: above v. below
the 10th percentile
0·211 20·021, 0·443 0·075
LF, long-chain PUFA-supplemented formula-fed group; CF, control formula-fed
group; BF, breast-fed group; OOS, Obstetrical Optimality Score.
*n 330; R 2 0·14; intercept for a CF male with birth weight 3·5 kg and OOS above
10th percentile, 1·7265.
Table 4. Neurological classification by nutritional group*







n % n % n %
Neurologically normal 68 54 44 48 56 46
Simple MND 46 36 35 39 48 39
Complex MND 13 10 12 13 19 15
BF, breast-fed; LF, long-chain PUFA-supplemented formula-fed; CF, control
formula-fed; MND, minor neurological dysfunction.
* No statistically significant differences were present between the groups.
Table 5. Results of logistic regression analysis of factors contributing
to fine manipulative dysfunction (explained variance of 18·5 %)
(Odds ratios and 95 % confidence intervals)
Contributing factors OR 95 % CI P
Type of feeding
BF (reference) 1
LF 2·668 1·3, 5·7 0·011
CF 2·548 1·3, 5·2 0·009
Covariates
Male sex 2·151 1·2, 3·9 0·010
OOS below the 10th percentile 7·271 2·3, 23 0·001
Maternal smoking 1·935 1·1, 3·6 0·034
Duration of 2nd part of delivery 0·989 0·98, 1 0·032
BF, breast-feeding; LF, long-chain PUFA-supplemented formula-feeding; CF,
control formula-feeding; OOS, Obstetrical Optimality Score.

















and neurological condition in particular, is in line with reports
of others(4,27,28). The association between breast-feeding and
neurological outcome was less strong than previously reported
by Lanting et al.(4), which may be attributed to differences in
the populations studied (Lanting et al. study: a mix of high-
risk and low-risk infants; present study: healthy full-term
infants) and the quality of the breast-feeding data (Lanting
et al. study: retrospectively collected information; present
study: detailed prospective information). Der et al.(29) were
able to demonstrate that maternal IQ accounted for a major
part of the association between breast-feeding and develop-
mental outcome in terms of IQ. In the present study, a
subtle association between breast-feeding and fine manipula-
tive ability remained, also when estimated maternal verbal
IQ was taken into account. Fine manipulative ability is
mediated especially by cortical–subcortical networks. These
networks do not only play a role in sensorimotor aspects of
motor programming, movement planning, program selection
and motor memory but also in cognitive functions, such as
intelligence(30,31). This means that the association between
breast-feeding and better fine manipulative ability corresponds
to reports of others of an association between breast-feeding
and higher IQ(27). Interestingly, the NOS data indicated
that especially girls profit from the beneficial effect of
breast-feeding. This sex-specific effect may be explained by
shared genome, and, albeit less likely, sex-specific differences
in metabolism of a-linolenic acid: adult women have a higher
conversion rate of a-linolenic acid to EPA and DHA than
adult men(32).
In conclusion, the present study indicates that LCPUFA
supplementation of formula during the first 2 postnatal
months in healthy term infants does not promote neurological
condition at school age. In addition, the study confirmed that
breast-fed infants have a slightly better neurodevelopmental
outcome than formula-fed infants – reflected in the present
study by a reduced prevalence of fine manipulative dysfunc-
tion. Finally, the study underscores the need of the evaluation
of selective attrition with respect to early developmental data
in studies assessing the effect of early nutrition on long-term
developmental outcome.
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